Pourazizi, M., Kabiri, S., & Abtahi-Naeini, B. (2017). Intralesional bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: A medical hypothesis. Journal of Research in Pharmacy Practice, 6(3), 190-191.
MLA
Mohsen Pourazizi; Sattar Kabiri; Bahareh Abtahi-Naeini. "Intralesional bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: A medical hypothesis", Journal of Research in Pharmacy Practice, 6, 3, 2017, 190-191.
HARVARD
Pourazizi, M., Kabiri, S., Abtahi-Naeini, B. (2017). 'Intralesional bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: A medical hypothesis', Journal of Research in Pharmacy Practice, 6(3), pp. 190-191.
VANCOUVER
Pourazizi, M., Kabiri, S., Abtahi-Naeini, B. Intralesional bevacizumab (Avastin®) as a novel addition to infantile hemangioma management: A medical hypothesis. Journal of Research in Pharmacy Practice, 2017; 6(3): 190-191.
)